Please login to the form below

Not currently logged in
Email:
Password:

Antibody cocktail

This page shows the latest Antibody cocktail news and features for those working in and with pharma, biotech and healthcare.

Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV

Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV

Regeneron has ended four clinical trials of its monoclonal antibody combination, REGEN-COV (casirivimab and imdevimab), according to the federal clinical trial database. ... Regeneron invented the antibody cocktail and is collaborating with Roche, the

Latest news

More from news
Approximately 2 fully matching, plus 38 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...